首页> 美国卫生研究院文献>BioMed Research International >Expression of Recombinant Human Coagulation Factor VII by the Lizard Leishmania Expression System
【2h】

Expression of Recombinant Human Coagulation Factor VII by the Lizard Leishmania Expression System

机译:蜥蜴利什曼原虫表达系统表达重组人凝血因子VII

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The variety of recombinant protein expression systems have been developed as a resource of FVII gene expression. In the current study, the authors used a novel protein expression system based on the Iranian Lizard Leishmania, a trypanosomatid protozoan as a host for expression of FVII. Plasmid containing cDNA encoding full-length human FVII was introduced into Lizard Leishmania and positive transfectants were analyzed by SDS-PAGE and Western blot analysis. Furthermore, biological activity of purified protein was detected by PT assay. The recombinant strain harboring a construct was analyzed for expression of FVII at the mRNA and protein level. Purified rFVII was obtained and in order to confirm the purified compound was in fact rFVII. Western blot analysis was carried out. Clotting time in PT assay was reduced about 30 seconds with the purified rFVII. In Conclusion, this study has demonstrated, for the first time, that Leishmania cells can be used as an expression system for producing recombinant FVII.
机译:已经开发了多种重组蛋白表达系统作为FVII基因表达的资源。在当前的研究中,作者使用了一种新颖的蛋白质表达系统,该系统基于伊朗蜥蜴利什曼原虫(一种锥虫原虫)作为FVII表达的宿主。将含有编码全长人FVII的cDNA的质粒引入蜥蜴利什曼原虫,并通过SDS-PAGE和蛋白质印迹分析来分析阳性转染子。此外,通过PT测定法检测纯化的蛋白质的生物学活性。分析了具有构建体的重组菌株在mRNA和蛋白质水平上的FVII表达。获得纯化的rFVII,并且为了确认纯化的化合物实际上是rFVII。进行蛋白质印迹分析。用纯化的rFVII将PT测定中的凝结时间减少约30秒。总之,这项研究首次证明利什曼原虫细胞可用作生产重组FVII的表达系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号